Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (PON01_02782)
Università degli Studi di Milano-Bicocca (FAR 2016-ATE-0599)
Lung Cancer Research Foundation (Targeting p65BTK in Non-Small Cell Lung Cancer)
Ministero della Salute (GR-2011-02351626)
Ministerio de Economía y Competitividad (SAF2013-46423-R and SAF2017-89944-R)
Received: 7 January 2019
Accepted: 29 April 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: All the samples were collected according to the national and international legislation. Patients’ informed consent was obtained and the study was approved by the Fondazione IRCCS Ca′ Granda Institutional Review Board (Institutional Review Board 179/2013; approval date: 19 March 2013). All clinical investigation has been conducted according to the principles expressed in the Declaration of Helsinki and data were analyzed anonymously according to the regulations.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.